Global Cell Therapy Regenerative Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Cell Therapy Regenerative Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 121

Published Date: 06 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

According to our (Global Info Research) latest study, the global Cell Therapy Regenerative Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The Global Info Research report includes an overview of the development of the Cell Therapy Regenerative Medicine industry chain, the market status of Hospital (NK Cell Therapy, CAR-T Cell Therapy), Medical Research Center (NK Cell Therapy, CAR-T Cell Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell Therapy Regenerative Medicine.

Regionally, the report analyzes the Cell Therapy Regenerative Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell Therapy Regenerative Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell Therapy Regenerative Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell Therapy Regenerative Medicine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., NK Cell Therapy, CAR-T Cell Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell Therapy Regenerative Medicine market.

Regional Analysis: The report involves examining the Cell Therapy Regenerative Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell Therapy Regenerative Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell Therapy Regenerative Medicine:
Company Analysis: Report covers individual Cell Therapy Regenerative Medicine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell Therapy Regenerative Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Medical Research Center).

Technology Analysis: Report covers specific technologies relevant to Cell Therapy Regenerative Medicine. It assesses the current state, advancements, and potential future developments in Cell Therapy Regenerative Medicine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell Therapy Regenerative Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell Therapy Regenerative Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
NK Cell Therapy
CAR-T Cell Therapy
Others

Market segment by Application
Hospital
Medical Research Center
Others

Major players covered
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cell Therapy Regenerative Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cell Therapy Regenerative Medicine, with price, sales, revenue and global market share of Cell Therapy Regenerative Medicine from 2018 to 2023.
Chapter 3, the Cell Therapy Regenerative Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell Therapy Regenerative Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cell Therapy Regenerative Medicine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cell Therapy Regenerative Medicine.
Chapter 14 and 15, to describe Cell Therapy Regenerative Medicine sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cell Therapy Regenerative Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cell Therapy Regenerative Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 NK Cell Therapy
1.3.3 CAR-T Cell Therapy
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Cell Therapy Regenerative Medicine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Medical Research Center
1.4.4 Others
1.5 Global Cell Therapy Regenerative Medicine Market Size & Forecast
1.5.1 Global Cell Therapy Regenerative Medicine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cell Therapy Regenerative Medicine Sales Quantity (2018-2029)
1.5.3 Global Cell Therapy Regenerative Medicine Average Price (2018-2029)

2 Manufacturers Profiles
2.1 DePuy Synthes
2.1.1 DePuy Synthes Details
2.1.2 DePuy Synthes Major Business
2.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
2.1.4 DePuy Synthes Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 DePuy Synthes Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Cell Therapy Regenerative Medicine Product and Services
2.2.4 Medtronic Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtronic Recent Developments/Updates
2.3 ZimmerBiomet
2.3.1 ZimmerBiomet Details
2.3.2 ZimmerBiomet Major Business
2.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
2.3.4 ZimmerBiomet Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ZimmerBiomet Recent Developments/Updates
2.4 Stryker
2.4.1 Stryker Details
2.4.2 Stryker Major Business
2.4.3 Stryker Cell Therapy Regenerative Medicine Product and Services
2.4.4 Stryker Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Stryker Recent Developments/Updates
2.5 Acelity
2.5.1 Acelity Details
2.5.2 Acelity Major Business
2.5.3 Acelity Cell Therapy Regenerative Medicine Product and Services
2.5.4 Acelity Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Acelity Recent Developments/Updates
2.6 MiMedx Group
2.6.1 MiMedx Group Details
2.6.2 MiMedx Group Major Business
2.6.3 MiMedx Group Cell Therapy Regenerative Medicine Product and Services
2.6.4 MiMedx Group Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 MiMedx Group Recent Developments/Updates
2.7 Organogenesis
2.7.1 Organogenesis Details
2.7.2 Organogenesis Major Business
2.7.3 Organogenesis Cell Therapy Regenerative Medicine Product and Services
2.7.4 Organogenesis Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Organogenesis Recent Developments/Updates
2.8 UniQure
2.8.1 UniQure Details
2.8.2 UniQure Major Business
2.8.3 UniQure Cell Therapy Regenerative Medicine Product and Services
2.8.4 UniQure Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 UniQure Recent Developments/Updates
2.9 Cellular Dynamics International
2.9.1 Cellular Dynamics International Details
2.9.2 Cellular Dynamics International Major Business
2.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
2.9.4 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cellular Dynamics International Recent Developments/Updates
2.10 Osiris Therapeutics
2.10.1 Osiris Therapeutics Details
2.10.2 Osiris Therapeutics Major Business
2.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
2.10.4 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Osiris Therapeutics Recent Developments/Updates
2.11 Vcanbio
2.11.1 Vcanbio Details
2.11.2 Vcanbio Major Business
2.11.3 Vcanbio Cell Therapy Regenerative Medicine Product and Services
2.11.4 Vcanbio Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Vcanbio Recent Developments/Updates
2.12 Gamida Cell
2.12.1 Gamida Cell Details
2.12.2 Gamida Cell Major Business
2.12.3 Gamida Cell Cell Therapy Regenerative Medicine Product and Services
2.12.4 Gamida Cell Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Gamida Cell Recent Developments/Updates
2.13 Golden Meditech
2.13.1 Golden Meditech Details
2.13.2 Golden Meditech Major Business
2.13.3 Golden Meditech Cell Therapy Regenerative Medicine Product and Services
2.13.4 Golden Meditech Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Golden Meditech Recent Developments/Updates
2.14 Cytori
2.14.1 Cytori Details
2.14.2 Cytori Major Business
2.14.3 Cytori Cell Therapy Regenerative Medicine Product and Services
2.14.4 Cytori Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Cytori Recent Developments/Updates
2.15 Celgene
2.15.1 Celgene Details
2.15.2 Celgene Major Business
2.15.3 Celgene Cell Therapy Regenerative Medicine Product and Services
2.15.4 Celgene Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Celgene Recent Developments/Updates
2.16 Vericel Corporation
2.16.1 Vericel Corporation Details
2.16.2 Vericel Corporation Major Business
2.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
2.16.4 Vericel Corporation Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Vericel Corporation Recent Developments/Updates
2.17 Guanhao Biotech
2.17.1 Guanhao Biotech Details
2.17.2 Guanhao Biotech Major Business
2.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
2.17.4 Guanhao Biotech Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Guanhao Biotech Recent Developments/Updates
2.18 Mesoblast
2.18.1 Mesoblast Details
2.18.2 Mesoblast Major Business
2.18.3 Mesoblast Cell Therapy Regenerative Medicine Product and Services
2.18.4 Mesoblast Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Mesoblast Recent Developments/Updates
2.19 Stemcell Technologies
2.19.1 Stemcell Technologies Details
2.19.2 Stemcell Technologies Major Business
2.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
2.19.4 Stemcell Technologies Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Stemcell Technologies Recent Developments/Updates
2.20 Bellicum Pharmaceuticals
2.20.1 Bellicum Pharmaceuticals Details
2.20.2 Bellicum Pharmaceuticals Major Business
2.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
2.20.4 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Bellicum Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Cell Therapy Regenerative Medicine by Manufacturer
3.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cell Therapy Regenerative Medicine Revenue by Manufacturer (2018-2023)
3.3 Global Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cell Therapy Regenerative Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cell Therapy Regenerative Medicine Manufacturer Market Share in 2022
3.4.2 Top 6 Cell Therapy Regenerative Medicine Manufacturer Market Share in 2022
3.5 Cell Therapy Regenerative Medicine Market: Overall Company Footprint Analysis
3.5.1 Cell Therapy Regenerative Medicine Market: Region Footprint
3.5.2 Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
3.5.3 Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Cell Therapy Regenerative Medicine Market Size by Region
4.1.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2029)
4.1.2 Global Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2029)
4.1.3 Global Cell Therapy Regenerative Medicine Average Price by Region (2018-2029)
4.2 North America Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.3 Europe Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.4 Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.5 South America Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.6 Middle East and Africa Cell Therapy Regenerative Medicine Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
5.2 Global Cell Therapy Regenerative Medicine Consumption Value by Type (2018-2029)
5.3 Global Cell Therapy Regenerative Medicine Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
6.2 Global Cell Therapy Regenerative Medicine Consumption Value by Application (2018-2029)
6.3 Global Cell Therapy Regenerative Medicine Average Price by Application (2018-2029)

7 North America
7.1 North America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
7.2 North America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
7.3 North America Cell Therapy Regenerative Medicine Market Size by Country
7.3.1 North America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
7.3.2 North America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
8.2 Europe Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
8.3 Europe Cell Therapy Regenerative Medicine Market Size by Country
8.3.1 Europe Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
8.3.2 Europe Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cell Therapy Regenerative Medicine Market Size by Region
9.3.1 Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
10.2 South America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
10.3 South America Cell Therapy Regenerative Medicine Market Size by Country
10.3.1 South America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
10.3.2 South America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cell Therapy Regenerative Medicine Market Size by Country
11.3.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Cell Therapy Regenerative Medicine Market Drivers
12.2 Cell Therapy Regenerative Medicine Market Restraints
12.3 Cell Therapy Regenerative Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Cell Therapy Regenerative Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cell Therapy Regenerative Medicine
13.3 Cell Therapy Regenerative Medicine Production Process
13.4 Cell Therapy Regenerative Medicine Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cell Therapy Regenerative Medicine Typical Distributors
14.3 Cell Therapy Regenerative Medicine Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cell Therapy Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell Therapy Regenerative Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. DePuy Synthes Basic Information, Manufacturing Base and Competitors
Table 4. DePuy Synthes Major Business
Table 5. DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
Table 6. DePuy Synthes Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. DePuy Synthes Recent Developments/Updates
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Major Business
Table 10. Medtronic Cell Therapy Regenerative Medicine Product and Services
Table 11. Medtronic Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Medtronic Recent Developments/Updates
Table 13. ZimmerBiomet Basic Information, Manufacturing Base and Competitors
Table 14. ZimmerBiomet Major Business
Table 15. ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
Table 16. ZimmerBiomet Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ZimmerBiomet Recent Developments/Updates
Table 18. Stryker Basic Information, Manufacturing Base and Competitors
Table 19. Stryker Major Business
Table 20. Stryker Cell Therapy Regenerative Medicine Product and Services
Table 21. Stryker Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Stryker Recent Developments/Updates
Table 23. Acelity Basic Information, Manufacturing Base and Competitors
Table 24. Acelity Major Business
Table 25. Acelity Cell Therapy Regenerative Medicine Product and Services
Table 26. Acelity Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Acelity Recent Developments/Updates
Table 28. MiMedx Group Basic Information, Manufacturing Base and Competitors
Table 29. MiMedx Group Major Business
Table 30. MiMedx Group Cell Therapy Regenerative Medicine Product and Services
Table 31. MiMedx Group Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. MiMedx Group Recent Developments/Updates
Table 33. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 34. Organogenesis Major Business
Table 35. Organogenesis Cell Therapy Regenerative Medicine Product and Services
Table 36. Organogenesis Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Organogenesis Recent Developments/Updates
Table 38. UniQure Basic Information, Manufacturing Base and Competitors
Table 39. UniQure Major Business
Table 40. UniQure Cell Therapy Regenerative Medicine Product and Services
Table 41. UniQure Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. UniQure Recent Developments/Updates
Table 43. Cellular Dynamics International Basic Information, Manufacturing Base and Competitors
Table 44. Cellular Dynamics International Major Business
Table 45. Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
Table 46. Cellular Dynamics International Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cellular Dynamics International Recent Developments/Updates
Table 48. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. Osiris Therapeutics Major Business
Table 50. Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
Table 51. Osiris Therapeutics Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Osiris Therapeutics Recent Developments/Updates
Table 53. Vcanbio Basic Information, Manufacturing Base and Competitors
Table 54. Vcanbio Major Business
Table 55. Vcanbio Cell Therapy Regenerative Medicine Product and Services
Table 56. Vcanbio Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Vcanbio Recent Developments/Updates
Table 58. Gamida Cell Basic Information, Manufacturing Base and Competitors
Table 59. Gamida Cell Major Business
Table 60. Gamida Cell Cell Therapy Regenerative Medicine Product and Services
Table 61. Gamida Cell Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Gamida Cell Recent Developments/Updates
Table 63. Golden Meditech Basic Information, Manufacturing Base and Competitors
Table 64. Golden Meditech Major Business
Table 65. Golden Meditech Cell Therapy Regenerative Medicine Product and Services
Table 66. Golden Meditech Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Golden Meditech Recent Developments/Updates
Table 68. Cytori Basic Information, Manufacturing Base and Competitors
Table 69. Cytori Major Business
Table 70. Cytori Cell Therapy Regenerative Medicine Product and Services
Table 71. Cytori Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Cytori Recent Developments/Updates
Table 73. Celgene Basic Information, Manufacturing Base and Competitors
Table 74. Celgene Major Business
Table 75. Celgene Cell Therapy Regenerative Medicine Product and Services
Table 76. Celgene Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Celgene Recent Developments/Updates
Table 78. Vericel Corporation Basic Information, Manufacturing Base and Competitors
Table 79. Vericel Corporation Major Business
Table 80. Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
Table 81. Vericel Corporation Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Vericel Corporation Recent Developments/Updates
Table 83. Guanhao Biotech Basic Information, Manufacturing Base and Competitors
Table 84. Guanhao Biotech Major Business
Table 85. Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
Table 86. Guanhao Biotech Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Guanhao Biotech Recent Developments/Updates
Table 88. Mesoblast Basic Information, Manufacturing Base and Competitors
Table 89. Mesoblast Major Business
Table 90. Mesoblast Cell Therapy Regenerative Medicine Product and Services
Table 91. Mesoblast Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Mesoblast Recent Developments/Updates
Table 93. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 94. Stemcell Technologies Major Business
Table 95. Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
Table 96. Stemcell Technologies Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Stemcell Technologies Recent Developments/Updates
Table 98. Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Bellicum Pharmaceuticals Major Business
Table 100. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
Table 101. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Bellicum Pharmaceuticals Recent Developments/Updates
Table 103. Global Cell Therapy Regenerative Medicine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Cell Therapy Regenerative Medicine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Cell Therapy Regenerative Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Cell Therapy Regenerative Medicine Production Site of Key Manufacturer
Table 108. Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
Table 109. Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
Table 110. Cell Therapy Regenerative Medicine New Market Entrants and Barriers to Market Entry
Table 111. Cell Therapy Regenerative Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Cell Therapy Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Cell Therapy Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Cell Therapy Regenerative Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Cell Therapy Regenerative Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Cell Therapy Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Cell Therapy Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Cell Therapy Regenerative Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Cell Therapy Regenerative Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Cell Therapy Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Cell Therapy Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Cell Therapy Regenerative Medicine Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Cell Therapy Regenerative Medicine Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Cell Therapy Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Cell Therapy Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Cell Therapy Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Cell Therapy Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Cell Therapy Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Cell Therapy Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Cell Therapy Regenerative Medicine Raw Material
Table 171. Key Manufacturers of Cell Therapy Regenerative Medicine Raw Materials
Table 172. Cell Therapy Regenerative Medicine Typical Distributors
Table 173. Cell Therapy Regenerative Medicine Typical Customers
List of Figures
Figure 1. Cell Therapy Regenerative Medicine Picture
Figure 2. Global Cell Therapy Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Type in 2022
Figure 4. NK Cell Therapy Examples
Figure 5. CAR-T Cell Therapy Examples
Figure 6. Others Examples
Figure 7. Global Cell Therapy Regenerative Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Medical Research Center Examples
Figure 11. Others Examples
Figure 12. Global Cell Therapy Regenerative Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Cell Therapy Regenerative Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Cell Therapy Regenerative Medicine Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Cell Therapy Regenerative Medicine Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Cell Therapy Regenerative Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Cell Therapy Regenerative Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Cell Therapy Regenerative Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Cell Therapy Regenerative Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Cell Therapy Regenerative Medicine Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Cell Therapy Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Cell Therapy Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Cell Therapy Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Cell Therapy Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Cell Therapy Regenerative Medicine Market Drivers
Figure 75. Cell Therapy Regenerative Medicine Market Restraints
Figure 76. Cell Therapy Regenerative Medicine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine in 2022
Figure 79. Manufacturing Process Analysis of Cell Therapy Regenerative Medicine
Figure 80. Cell Therapy Regenerative Medicine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Cell Therapy Regenerative Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Cell Therapy Regenerative Medicine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 121

Published Date: 06 Aug 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

According to our (Global Info Research) latest study, the global Cell Therapy Regenerative Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.

Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

The Global Info Research report includes an overview of the development of the Cell Therapy Regenerative Medicine industry chain, the market status of Hospital (NK Cell Therapy, CAR-T Cell Therapy), Medical Research Center (NK Cell Therapy, CAR-T Cell Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell Therapy Regenerative Medicine.

Regionally, the report analyzes the Cell Therapy Regenerative Medicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell Therapy Regenerative Medicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Cell Therapy Regenerative Medicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell Therapy Regenerative Medicine industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., NK Cell Therapy, CAR-T Cell Therapy).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell Therapy Regenerative Medicine market.

Regional Analysis: The report involves examining the Cell Therapy Regenerative Medicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell Therapy Regenerative Medicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Cell Therapy Regenerative Medicine:
Company Analysis: Report covers individual Cell Therapy Regenerative Medicine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell Therapy Regenerative Medicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Medical Research Center).

Technology Analysis: Report covers specific technologies relevant to Cell Therapy Regenerative Medicine. It assesses the current state, advancements, and potential future developments in Cell Therapy Regenerative Medicine areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell Therapy Regenerative Medicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Cell Therapy Regenerative Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
NK Cell Therapy
CAR-T Cell Therapy
Others

Market segment by Application
Hospital
Medical Research Center
Others

Major players covered
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cell Therapy Regenerative Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cell Therapy Regenerative Medicine, with price, sales, revenue and global market share of Cell Therapy Regenerative Medicine from 2018 to 2023.
Chapter 3, the Cell Therapy Regenerative Medicine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell Therapy Regenerative Medicine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cell Therapy Regenerative Medicine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cell Therapy Regenerative Medicine.
Chapter 14 and 15, to describe Cell Therapy Regenerative Medicine sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Cell Therapy Regenerative Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cell Therapy Regenerative Medicine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 NK Cell Therapy
1.3.3 CAR-T Cell Therapy
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Cell Therapy Regenerative Medicine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Medical Research Center
1.4.4 Others
1.5 Global Cell Therapy Regenerative Medicine Market Size & Forecast
1.5.1 Global Cell Therapy Regenerative Medicine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cell Therapy Regenerative Medicine Sales Quantity (2018-2029)
1.5.3 Global Cell Therapy Regenerative Medicine Average Price (2018-2029)

2 Manufacturers Profiles
2.1 DePuy Synthes
2.1.1 DePuy Synthes Details
2.1.2 DePuy Synthes Major Business
2.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
2.1.4 DePuy Synthes Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 DePuy Synthes Recent Developments/Updates
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Cell Therapy Regenerative Medicine Product and Services
2.2.4 Medtronic Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtronic Recent Developments/Updates
2.3 ZimmerBiomet
2.3.1 ZimmerBiomet Details
2.3.2 ZimmerBiomet Major Business
2.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
2.3.4 ZimmerBiomet Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 ZimmerBiomet Recent Developments/Updates
2.4 Stryker
2.4.1 Stryker Details
2.4.2 Stryker Major Business
2.4.3 Stryker Cell Therapy Regenerative Medicine Product and Services
2.4.4 Stryker Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Stryker Recent Developments/Updates
2.5 Acelity
2.5.1 Acelity Details
2.5.2 Acelity Major Business
2.5.3 Acelity Cell Therapy Regenerative Medicine Product and Services
2.5.4 Acelity Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Acelity Recent Developments/Updates
2.6 MiMedx Group
2.6.1 MiMedx Group Details
2.6.2 MiMedx Group Major Business
2.6.3 MiMedx Group Cell Therapy Regenerative Medicine Product and Services
2.6.4 MiMedx Group Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 MiMedx Group Recent Developments/Updates
2.7 Organogenesis
2.7.1 Organogenesis Details
2.7.2 Organogenesis Major Business
2.7.3 Organogenesis Cell Therapy Regenerative Medicine Product and Services
2.7.4 Organogenesis Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Organogenesis Recent Developments/Updates
2.8 UniQure
2.8.1 UniQure Details
2.8.2 UniQure Major Business
2.8.3 UniQure Cell Therapy Regenerative Medicine Product and Services
2.8.4 UniQure Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 UniQure Recent Developments/Updates
2.9 Cellular Dynamics International
2.9.1 Cellular Dynamics International Details
2.9.2 Cellular Dynamics International Major Business
2.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
2.9.4 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Cellular Dynamics International Recent Developments/Updates
2.10 Osiris Therapeutics
2.10.1 Osiris Therapeutics Details
2.10.2 Osiris Therapeutics Major Business
2.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
2.10.4 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Osiris Therapeutics Recent Developments/Updates
2.11 Vcanbio
2.11.1 Vcanbio Details
2.11.2 Vcanbio Major Business
2.11.3 Vcanbio Cell Therapy Regenerative Medicine Product and Services
2.11.4 Vcanbio Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Vcanbio Recent Developments/Updates
2.12 Gamida Cell
2.12.1 Gamida Cell Details
2.12.2 Gamida Cell Major Business
2.12.3 Gamida Cell Cell Therapy Regenerative Medicine Product and Services
2.12.4 Gamida Cell Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Gamida Cell Recent Developments/Updates
2.13 Golden Meditech
2.13.1 Golden Meditech Details
2.13.2 Golden Meditech Major Business
2.13.3 Golden Meditech Cell Therapy Regenerative Medicine Product and Services
2.13.4 Golden Meditech Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Golden Meditech Recent Developments/Updates
2.14 Cytori
2.14.1 Cytori Details
2.14.2 Cytori Major Business
2.14.3 Cytori Cell Therapy Regenerative Medicine Product and Services
2.14.4 Cytori Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Cytori Recent Developments/Updates
2.15 Celgene
2.15.1 Celgene Details
2.15.2 Celgene Major Business
2.15.3 Celgene Cell Therapy Regenerative Medicine Product and Services
2.15.4 Celgene Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Celgene Recent Developments/Updates
2.16 Vericel Corporation
2.16.1 Vericel Corporation Details
2.16.2 Vericel Corporation Major Business
2.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
2.16.4 Vericel Corporation Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Vericel Corporation Recent Developments/Updates
2.17 Guanhao Biotech
2.17.1 Guanhao Biotech Details
2.17.2 Guanhao Biotech Major Business
2.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
2.17.4 Guanhao Biotech Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Guanhao Biotech Recent Developments/Updates
2.18 Mesoblast
2.18.1 Mesoblast Details
2.18.2 Mesoblast Major Business
2.18.3 Mesoblast Cell Therapy Regenerative Medicine Product and Services
2.18.4 Mesoblast Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Mesoblast Recent Developments/Updates
2.19 Stemcell Technologies
2.19.1 Stemcell Technologies Details
2.19.2 Stemcell Technologies Major Business
2.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
2.19.4 Stemcell Technologies Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Stemcell Technologies Recent Developments/Updates
2.20 Bellicum Pharmaceuticals
2.20.1 Bellicum Pharmaceuticals Details
2.20.2 Bellicum Pharmaceuticals Major Business
2.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
2.20.4 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Bellicum Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Cell Therapy Regenerative Medicine by Manufacturer
3.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cell Therapy Regenerative Medicine Revenue by Manufacturer (2018-2023)
3.3 Global Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cell Therapy Regenerative Medicine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cell Therapy Regenerative Medicine Manufacturer Market Share in 2022
3.4.2 Top 6 Cell Therapy Regenerative Medicine Manufacturer Market Share in 2022
3.5 Cell Therapy Regenerative Medicine Market: Overall Company Footprint Analysis
3.5.1 Cell Therapy Regenerative Medicine Market: Region Footprint
3.5.2 Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
3.5.3 Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Cell Therapy Regenerative Medicine Market Size by Region
4.1.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2029)
4.1.2 Global Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2029)
4.1.3 Global Cell Therapy Regenerative Medicine Average Price by Region (2018-2029)
4.2 North America Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.3 Europe Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.4 Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.5 South America Cell Therapy Regenerative Medicine Consumption Value (2018-2029)
4.6 Middle East and Africa Cell Therapy Regenerative Medicine Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
5.2 Global Cell Therapy Regenerative Medicine Consumption Value by Type (2018-2029)
5.3 Global Cell Therapy Regenerative Medicine Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
6.2 Global Cell Therapy Regenerative Medicine Consumption Value by Application (2018-2029)
6.3 Global Cell Therapy Regenerative Medicine Average Price by Application (2018-2029)

7 North America
7.1 North America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
7.2 North America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
7.3 North America Cell Therapy Regenerative Medicine Market Size by Country
7.3.1 North America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
7.3.2 North America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
8.2 Europe Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
8.3 Europe Cell Therapy Regenerative Medicine Market Size by Country
8.3.1 Europe Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
8.3.2 Europe Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cell Therapy Regenerative Medicine Market Size by Region
9.3.1 Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
10.2 South America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
10.3 South America Cell Therapy Regenerative Medicine Market Size by Country
10.3.1 South America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
10.3.2 South America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cell Therapy Regenerative Medicine Market Size by Country
11.3.1 Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Cell Therapy Regenerative Medicine Market Drivers
12.2 Cell Therapy Regenerative Medicine Market Restraints
12.3 Cell Therapy Regenerative Medicine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Cell Therapy Regenerative Medicine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cell Therapy Regenerative Medicine
13.3 Cell Therapy Regenerative Medicine Production Process
13.4 Cell Therapy Regenerative Medicine Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cell Therapy Regenerative Medicine Typical Distributors
14.3 Cell Therapy Regenerative Medicine Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Cell Therapy Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell Therapy Regenerative Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. DePuy Synthes Basic Information, Manufacturing Base and Competitors
Table 4. DePuy Synthes Major Business
Table 5. DePuy Synthes Cell Therapy Regenerative Medicine Product and Services
Table 6. DePuy Synthes Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. DePuy Synthes Recent Developments/Updates
Table 8. Medtronic Basic Information, Manufacturing Base and Competitors
Table 9. Medtronic Major Business
Table 10. Medtronic Cell Therapy Regenerative Medicine Product and Services
Table 11. Medtronic Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Medtronic Recent Developments/Updates
Table 13. ZimmerBiomet Basic Information, Manufacturing Base and Competitors
Table 14. ZimmerBiomet Major Business
Table 15. ZimmerBiomet Cell Therapy Regenerative Medicine Product and Services
Table 16. ZimmerBiomet Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. ZimmerBiomet Recent Developments/Updates
Table 18. Stryker Basic Information, Manufacturing Base and Competitors
Table 19. Stryker Major Business
Table 20. Stryker Cell Therapy Regenerative Medicine Product and Services
Table 21. Stryker Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Stryker Recent Developments/Updates
Table 23. Acelity Basic Information, Manufacturing Base and Competitors
Table 24. Acelity Major Business
Table 25. Acelity Cell Therapy Regenerative Medicine Product and Services
Table 26. Acelity Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Acelity Recent Developments/Updates
Table 28. MiMedx Group Basic Information, Manufacturing Base and Competitors
Table 29. MiMedx Group Major Business
Table 30. MiMedx Group Cell Therapy Regenerative Medicine Product and Services
Table 31. MiMedx Group Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. MiMedx Group Recent Developments/Updates
Table 33. Organogenesis Basic Information, Manufacturing Base and Competitors
Table 34. Organogenesis Major Business
Table 35. Organogenesis Cell Therapy Regenerative Medicine Product and Services
Table 36. Organogenesis Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Organogenesis Recent Developments/Updates
Table 38. UniQure Basic Information, Manufacturing Base and Competitors
Table 39. UniQure Major Business
Table 40. UniQure Cell Therapy Regenerative Medicine Product and Services
Table 41. UniQure Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. UniQure Recent Developments/Updates
Table 43. Cellular Dynamics International Basic Information, Manufacturing Base and Competitors
Table 44. Cellular Dynamics International Major Business
Table 45. Cellular Dynamics International Cell Therapy Regenerative Medicine Product and Services
Table 46. Cellular Dynamics International Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Cellular Dynamics International Recent Developments/Updates
Table 48. Osiris Therapeutics Basic Information, Manufacturing Base and Competitors
Table 49. Osiris Therapeutics Major Business
Table 50. Osiris Therapeutics Cell Therapy Regenerative Medicine Product and Services
Table 51. Osiris Therapeutics Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Osiris Therapeutics Recent Developments/Updates
Table 53. Vcanbio Basic Information, Manufacturing Base and Competitors
Table 54. Vcanbio Major Business
Table 55. Vcanbio Cell Therapy Regenerative Medicine Product and Services
Table 56. Vcanbio Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Vcanbio Recent Developments/Updates
Table 58. Gamida Cell Basic Information, Manufacturing Base and Competitors
Table 59. Gamida Cell Major Business
Table 60. Gamida Cell Cell Therapy Regenerative Medicine Product and Services
Table 61. Gamida Cell Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Gamida Cell Recent Developments/Updates
Table 63. Golden Meditech Basic Information, Manufacturing Base and Competitors
Table 64. Golden Meditech Major Business
Table 65. Golden Meditech Cell Therapy Regenerative Medicine Product and Services
Table 66. Golden Meditech Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Golden Meditech Recent Developments/Updates
Table 68. Cytori Basic Information, Manufacturing Base and Competitors
Table 69. Cytori Major Business
Table 70. Cytori Cell Therapy Regenerative Medicine Product and Services
Table 71. Cytori Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Cytori Recent Developments/Updates
Table 73. Celgene Basic Information, Manufacturing Base and Competitors
Table 74. Celgene Major Business
Table 75. Celgene Cell Therapy Regenerative Medicine Product and Services
Table 76. Celgene Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Celgene Recent Developments/Updates
Table 78. Vericel Corporation Basic Information, Manufacturing Base and Competitors
Table 79. Vericel Corporation Major Business
Table 80. Vericel Corporation Cell Therapy Regenerative Medicine Product and Services
Table 81. Vericel Corporation Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Vericel Corporation Recent Developments/Updates
Table 83. Guanhao Biotech Basic Information, Manufacturing Base and Competitors
Table 84. Guanhao Biotech Major Business
Table 85. Guanhao Biotech Cell Therapy Regenerative Medicine Product and Services
Table 86. Guanhao Biotech Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Guanhao Biotech Recent Developments/Updates
Table 88. Mesoblast Basic Information, Manufacturing Base and Competitors
Table 89. Mesoblast Major Business
Table 90. Mesoblast Cell Therapy Regenerative Medicine Product and Services
Table 91. Mesoblast Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Mesoblast Recent Developments/Updates
Table 93. Stemcell Technologies Basic Information, Manufacturing Base and Competitors
Table 94. Stemcell Technologies Major Business
Table 95. Stemcell Technologies Cell Therapy Regenerative Medicine Product and Services
Table 96. Stemcell Technologies Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Stemcell Technologies Recent Developments/Updates
Table 98. Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 99. Bellicum Pharmaceuticals Major Business
Table 100. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Product and Services
Table 101. Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Bellicum Pharmaceuticals Recent Developments/Updates
Table 103. Global Cell Therapy Regenerative Medicine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global Cell Therapy Regenerative Medicine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global Cell Therapy Regenerative Medicine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in Cell Therapy Regenerative Medicine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and Cell Therapy Regenerative Medicine Production Site of Key Manufacturer
Table 108. Cell Therapy Regenerative Medicine Market: Company Product Type Footprint
Table 109. Cell Therapy Regenerative Medicine Market: Company Product Application Footprint
Table 110. Cell Therapy Regenerative Medicine New Market Entrants and Barriers to Market Entry
Table 111. Cell Therapy Regenerative Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global Cell Therapy Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global Cell Therapy Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global Cell Therapy Regenerative Medicine Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global Cell Therapy Regenerative Medicine Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global Cell Therapy Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global Cell Therapy Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global Cell Therapy Regenerative Medicine Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global Cell Therapy Regenerative Medicine Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global Cell Therapy Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global Cell Therapy Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global Cell Therapy Regenerative Medicine Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global Cell Therapy Regenerative Medicine Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America Cell Therapy Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America Cell Therapy Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe Cell Therapy Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Cell Therapy Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America Cell Therapy Regenerative Medicine Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America Cell Therapy Regenerative Medicine Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America Cell Therapy Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America Cell Therapy Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 170. Cell Therapy Regenerative Medicine Raw Material
Table 171. Key Manufacturers of Cell Therapy Regenerative Medicine Raw Materials
Table 172. Cell Therapy Regenerative Medicine Typical Distributors
Table 173. Cell Therapy Regenerative Medicine Typical Customers
List of Figures
Figure 1. Cell Therapy Regenerative Medicine Picture
Figure 2. Global Cell Therapy Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Type in 2022
Figure 4. NK Cell Therapy Examples
Figure 5. CAR-T Cell Therapy Examples
Figure 6. Others Examples
Figure 7. Global Cell Therapy Regenerative Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Application in 2022
Figure 9. Hospital Examples
Figure 10. Medical Research Center Examples
Figure 11. Others Examples
Figure 12. Global Cell Therapy Regenerative Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Cell Therapy Regenerative Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Cell Therapy Regenerative Medicine Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Cell Therapy Regenerative Medicine Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Cell Therapy Regenerative Medicine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Cell Therapy Regenerative Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Cell Therapy Regenerative Medicine Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Cell Therapy Regenerative Medicine Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Cell Therapy Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Cell Therapy Regenerative Medicine Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Cell Therapy Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Cell Therapy Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Cell Therapy Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Cell Therapy Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Cell Therapy Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 54. China Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Cell Therapy Regenerative Medicine Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Cell Therapy Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Cell Therapy Regenerative Medicine Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Cell Therapy Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Cell Therapy Regenerative Medicine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Cell Therapy Regenerative Medicine Market Drivers
Figure 75. Cell Therapy Regenerative Medicine Market Restraints
Figure 76. Cell Therapy Regenerative Medicine Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Cell Therapy Regenerative Medicine in 2022
Figure 79. Manufacturing Process Analysis of Cell Therapy Regenerative Medicine
Figure 80. Cell Therapy Regenerative Medicine Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
jiaGou

Add To Cart

gouMai

Buy Now